Ergocalciferol — $0 with Membership
Ergocalciferol has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Ergocalciferol Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $89.99 |
Free with membership subject to the listed formulary limits.
About Ergocalciferol
Ergocalciferol is a prescription medication. Ask your doctor if Ergocalciferol is right for you.
Conditions Treated with Ergocalciferol
How to Check Ergocalciferol Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Ergocalciferol at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Related medications
Other medications associated with the same conditions in this catalog.
Also listed for Vitamin D Deficiency
Other medications in Endocrine
What Ergocalciferol is approved for (FDA label)
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Source: Read the full FDA label on DailyMed. Label effective date: September 4, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Ergocalciferol (FDA label)
Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism) vague aches, stiffness, and weakness. Gastrointestinal: Nausea, anorexia, constipation. Metabolic: Mild acidosis, anemia, weight loss. To report SUSPECTED ADVERSE REACTIONS, contact Torrent Pharma Inc. at 1-800-912-9561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Source: FDA prescribing information (DailyMed). Set ID: 4ae38744-020d-4c37-a6f1-88f55c2f1047. SPL document ID: b427fa56-1a5b-4826-9034-e82c697381d3. Label effective date: September 4, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Ergocalciferol (FDA label)
Ergocalciferol is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
Source: FDA prescribing information (DailyMed). Set ID: 4ae38744-020d-4c37-a6f1-88f55c2f1047. SPL document ID: b427fa56-1a5b-4826-9034-e82c697381d3. Label effective date: September 4, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Ergocalciferol (FDA label)
Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations. Administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia.
Source: FDA prescribing information (DailyMed). Set ID: 4ae38744-020d-4c37-a6f1-88f55c2f1047. SPL document ID: b427fa56-1a5b-4826-9034-e82c697381d3. Label effective date: September 4, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.